![Michael Ferraresso](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michael Ferraresso
Corporate Officer/Principal bij AVEO PHARMACEUTICALS, INC.
Profiel
Michael Ferraresso is currently the Chief Commercial Officer at AVEO Pharmaceuticals, Inc. He previously worked as the Vice President-Commercial at Infinity Pharmaceuticals, Inc. from 2013 to 2017.
In 2017, he also briefly served as the Vice President-Commercial Operations at Verastem, Inc. Mr. Ferraresso completed his undergraduate degree at Assumption College.
Actieve functies van Michael Ferraresso
Bedrijven | Functie | Begin |
---|---|---|
AVEO PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-12-2017 |
Eerdere bekende functies van Michael Ferraresso
Bedrijven | Functie | Einde |
---|---|---|
VERASTEM, INC. | Corporate Officer/Principal | 01-11-2017 |
INFINITY PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-01-2017 |
Opleiding van Michael Ferraresso
Assumption College | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
VERASTEM, INC. | Health Technology |
INFINITY PHARMACEUTICALS, INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
AVEO Pharmaceuticals, Inc.
![]() AVEO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AVEO Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the advancement of therapeutics for oncology, and other areas of unmet medical need. Its product candidates include Tivozanib, Ficlatuzmab, AV-203, AV-380 and AV-353. The company was founded by Ronald A. DePinho, Lynda Chin, and Kenneth E. Weg on October 19, 2001 and is headquartered in Cambridge, MA. | Health Technology |